Evidence map›Paper›PMID 40059964›Full record

ArticleSmart medicine2025

Biomineralize Mitochondria in Metal-Organic Frameworks to Promote Mitochondria Transplantation From Non-Tumorigenic Cells Into Cancer Cells.

Jun-Nian Zhou, Chang Liu, Yonghui Wang, Yong Guo, Xiao-Yu Xu, Elina Vuorimaa-Laukkanen, Oliver Koivisto, Anne M Filppula, Jiangbin Ye, Hongbo Zhang

Abstract read
In one paragraph

Article in Smart medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jun-Nian ZhouPharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.ORCID https://orcid.org/0000-0002-7782-234X
Chang LiuPharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.
Yonghui WangPharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.
Yong GuoPharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.
Xiao-Yu XuPharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.
Elina Vuorimaa-LaukkanenChemistry and Advanced Materials Faculty of Engineering and Natural Sciences Tampere University Tampere Finland.
Oliver KoivistoPharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.
Anne M FilppulaPharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.
Jiangbin YeDepartment of Radiation Oncology Stanford University School of Medicine Stanford California USA.
Hongbo ZhangPharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria are crucial to cellular physiology, and growing evidence highlights the significant impact of mitochondrial dysfunction in diabetes, aging, neurodegenerative disorders, and cancers. Therefore, mitochondrial transplantation shows great potential for therapeutic use in treating these diseases. However, transplantation process is notably challenging due to very low efficiency and rapid loss of bioactivity post-isolation, leading to poor reproducibility and reliability. In this study, we develop a novel strategy to form a nanometer-thick protective shell around isolated mitochondria using Metal-Organic Frameworks (MOFs) through biomineralization. Our findings demonstrate that this encapsulation method effectively maintains mitochondria bioactivity for at least 4 weeks at room temperature. Furthermore, the efficiency of intracellular delivery of mitochondria is significantly enhanced through the surface functionalization of MOFs with polyethyleneimine (PEI) and the cell-penetrating peptide Tat. The successful delivery of mitochondria isolated from non-tumorigenic cells into cancer cells results in notable tumor-suppressive effects. Taken together, our technology represents a significant advancement in mitochondria research, particularly on understanding their role in cancer. It also lays the groundwork for utilizing mitochondria as therapeutic agents in cancer treatment.

Indexed as

biomineralizationcancer cellsmetal‐organic frameworksmitochondriamitochondria transplantation

Identifiers

PMID40059964
PMCPMC11862567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.